Silicon Laboratories (NASDAQ: SLAB) that Barclais reduced the price of its target from $ 100 to $ 90 in a report released on Tuesday, October 23. Barclais currently has the same rating for a semi-official company.
Several other brokers also released SLAB reports. Zacks Investment Research upgraded the Silicon Laboratories shares from a post-acquisition rating and set a price of $ 107.00 in a research notebook on Tuesday, July 31st. B. Riley raised its price target to Silicon Laboratories at $ 123.00 and gave the company a purchase in the research report on Wednesday, July 25th. On Tuesday, July 10th, BidaskClub raised the Silicon Laboratories shares from the rating to the purchase rating in the research report. Loop Capital cut its target price for Silicon Laboratories for $ 110.00 and set a rating for the company in its research report on Thursday, July 26th. In the end, ValuEngine reported on Thursday, September 27th, on a rating of value in relation to the estimated value of Silicon Laboratories purchase. One research analyst rated the rating with sales rating, six rated for rating and seven bought the rating company. The company currently has an average Hold rating and a target price of $ 105.27.
Nasdaq shares: SLAB traded on Tuesday for $ 2.90 a day, reaching $ 85.11. 131,389 shares of the company were replaced, compared with an average volume of 268,141. Silicon Laboratories has a value of fifty-two weeks from $ 75.89 and a high of fifty-two weeks from $ 110.70. The company has a quick ratio of 4.91, a current ratio of 5.44 and a debt ratio of 0.34. The firm has a market cap of $ 3.49 billion, a ratio of price and earnings ratio of 36.22, a PEG ratio of 1.94 and a beta of 1.60.
Silicon Laboratories (Nasdaq: SLAB) released quarterly revenue data on Wednesday, October 24th. A semiconductor company posted 1.01 euros EPS for the quarter, based on analysts' consensus estimates of $ 0.98 for $ 0.03. Silicon laboratories had a net margin of 7.45% and a return on equity of 12.48%. The business generated revenue of $ 230.20 million for a quarter, compared with an estimated analyst at $ 227.36 million. During the same period last year, the business announced earnings of $ 0.90 per share. The company's quarterly revenue increased by 15.9% annually. Research analysts expect Silicon Laboratories to publish 2.77 earnings per share for the current fiscal year.
In other news from Silicon Laboratories, SVP Alessandro Piovaccari sold 1,404 shares of Silicon Laboratories in a transaction dated Monday, October 15. The shares were sold at an average price of 80.72 dollars, in the total value of 113,330.88 dollars. Upon completion of the sale, the senior vice president now owns 28,265 shares in the company, valued at approximately 2,281,550.80 USD. The sale was disclosed in a note by the Securities and Exchange Commission, which is available through the SEC website. Also, director Villiam G. Bock sold 1,000 shares of business capital in a transaction that took place on Thursday, November 15th. The shares were sold at an average price of $ 82.75, for a total transaction of $ 82,750.00. Upon completion of the transaction, the director now has 39,751 shares of the company, worth 3,289,395.25 dollars. The explanation for this sale can be found here. In the last quarter, insiders sold a total of 3,809 shares of the company, worth $ 326,605. Corporate insiders own 1.96% shares of the company.
Several major investors have recently changed their assets to SLAB. Frontier Capital Management Co. LLC increased its position in Silicon Laboratories by 310.3% during the third quarter. Frontier Capital Management Co. LLC now owns 551,776 shares of a semiconductor holding in the amount of 50,653,000 dollars after it acquired an additional 417,299 shares in the last quarter. Eagle Asset Management Inc. increased its position in Silicon Laboratories by 54.0% in the second quarter. Eagle Asset Management Inc. now owns 511,076 shares of a semiconductor share of $ 50,903,000 after it acquired an additional 179,120 shares in the last quarter. Advisors Asset Management Inc. increased its position in Silicon Laboratories by 7,462.3% in the second quarter. Advisors Asset Management Inc. now owns 159,187 shares of a semiconductor company worth 224,000 dollars after purchasing an additional 157,082 shares in the last quarter. Millennium Management LLC increased its position in Silicon Laboratories by 188.8% during the first quarter. Millennium Management LLC now owns 200,266 shares of a semiconductor holding at $ 18,004,000 after buying an additional 130,928 shares in the last quarter. Finally, FMR LLC increased its position in Silicon Laboratories by 1.2% in the second quarter. FMR LLC now owns 6,484,660 shares of the semiconductor company's stake of $ 645,872,000 after purchasing an additional 75,633 shares in the last quarter. Institutional investors own 92.37% of shares of the company.
Company profile Silicon Laboratories
Silicon Laboratories Inc., a semiconductor manufacturing company, designs, develops and markets mixed-signal integrated circuits (ICs) in the United States, China and internationally. The company offers Internet stuff products, such as 8-bit mixed signal, 32-bit wireless and 32-bit ultra-low power microcontrollers; wireless devices, including multiprotocol wireless Gecko systems on the chip; operating systems in real time; Sensor products containing optical, relative humidity / temperature and magnetic sensors with a recording effect.
Read more: Market capitalization
You receive news and ratings for Silicon Laboratories Daili – Enter your email address below to get a concise daily review of the latest news and analysts for Silicon Laboratories and related companies with the FREE Daily MarketBeat.com newsletter.